Established in April 2003, BIONIME is specialized in biotechnology and medical device business. Self Monitoring Blood Glucose System (SMBG) for home use as well as devices and software solutions for Point of Care Testing (POCT) and IOT solutions are in BIONIMEs product portfolio. BIONIME integrates the top-tier expertise in medical science, chemistry, electronics and precision mechanism to commercialize the patent protected unique test strip technology.
BIONIME employs more than 900 employees and operates five subsidiaries in major markets, Europe, America and Asia. The products have been highly recognized by outstanding clinical tests and well-known journals internationally and successfully distributed into the worldwide markets.